[go: up one dir, main page]

FR2847818B1 - PHARMACEUTICAL COMPOSITION BASED ON HYALURONIC ACID - Google Patents

PHARMACEUTICAL COMPOSITION BASED ON HYALURONIC ACID

Info

Publication number
FR2847818B1
FR2847818B1 FR0214979A FR0214979A FR2847818B1 FR 2847818 B1 FR2847818 B1 FR 2847818B1 FR 0214979 A FR0214979 A FR 0214979A FR 0214979 A FR0214979 A FR 0214979A FR 2847818 B1 FR2847818 B1 FR 2847818B1
Authority
FR
France
Prior art keywords
pharmaceutical composition
hyaluronic acid
composition based
hyaluronic
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR0214979A
Other languages
French (fr)
Other versions
FR2847818A1 (en
Inventor
Edith Puchelle
Jean Marie Zahm
Martine Briet
Beatrice Raby
Baynast Regis De
Franck Launay
Anthony Bresin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Agro Industrie Recherches et Developpements ARD
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Agro Industrie Recherches et Developpements ARD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM, Agro Industrie Recherches et Developpements ARD filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Priority to FR0214979A priority Critical patent/FR2847818B1/en
Priority to AU2003294100A priority patent/AU2003294100A1/en
Priority to PCT/FR2003/003507 priority patent/WO2004050187A1/en
Publication of FR2847818A1 publication Critical patent/FR2847818A1/en
Application granted granted Critical
Publication of FR2847818B1 publication Critical patent/FR2847818B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/12Mucolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR0214979A 2002-11-28 2002-11-28 PHARMACEUTICAL COMPOSITION BASED ON HYALURONIC ACID Expired - Lifetime FR2847818B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR0214979A FR2847818B1 (en) 2002-11-28 2002-11-28 PHARMACEUTICAL COMPOSITION BASED ON HYALURONIC ACID
AU2003294100A AU2003294100A1 (en) 2002-11-28 2003-11-27 Use of hyaluronic acid for respiratory disorders or the upper airways
PCT/FR2003/003507 WO2004050187A1 (en) 2002-11-28 2003-11-27 Use of hyaluronic acid for respiratory disorders or the upper airways

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0214979A FR2847818B1 (en) 2002-11-28 2002-11-28 PHARMACEUTICAL COMPOSITION BASED ON HYALURONIC ACID

Publications (2)

Publication Number Publication Date
FR2847818A1 FR2847818A1 (en) 2004-06-04
FR2847818B1 true FR2847818B1 (en) 2008-04-04

Family

ID=32309802

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0214979A Expired - Lifetime FR2847818B1 (en) 2002-11-28 2002-11-28 PHARMACEUTICAL COMPOSITION BASED ON HYALURONIC ACID

Country Status (3)

Country Link
AU (1) AU2003294100A1 (en)
FR (1) FR2847818B1 (en)
WO (1) WO2004050187A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101801391B (en) * 2007-07-23 2013-07-10 农业工业研究发展公司 Use of hyaluronic acid for preparing compositions particularly for improving the function of skin, eye and mucous membrane protection

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060183709A1 (en) * 2005-02-15 2006-08-17 Ahmad Alkayali Preparation of low molecular weight hyaluronic acid as a food supplement
ITMI20060742A1 (en) 2006-04-13 2007-10-14 Patrizia Pattini ANTIBACTERIAL COMPOSITIONS FOR TREATMENT OF INFECTION OF HIGH AND LOW AIRCRAFT
IT1396468B1 (en) * 2008-11-11 2012-12-14 Farma Derma Srl TOPIC USE OF HYALURONIC ACID FOR FILMOGEN ACTION IN PREPARATIONS FOR TREATMENT AND PROPHYLAXIS OF PATHOLOGIES OF THE RESPIRATORY PATHWAYS.
EP2985019B1 (en) 2014-08-16 2021-10-20 Church & Dwight Co., Inc. Nasal composition having anti-viral properties
EP2985027B1 (en) 2014-08-16 2021-03-31 Church & Dwight Co., Inc. Nasal composition comprising mixture of hyaluronic acids and saline solution
EP3415154A1 (en) 2017-06-16 2018-12-19 Sofibel S.A.S. Nasal composition
EP4426317A1 (en) 2021-11-05 2024-09-11 INSERM (Institut National de la Santé et de la Recherche Médicale) Use of low molecular weight hyaluronic acid for the treatment of lung mucosal inflammation
WO2024194437A1 (en) 2023-03-22 2024-09-26 Institut National de la Santé et de la Recherche Médicale Use of low molecular weight hyaluronic acid for promoting ciliated cell differentiation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3310994B2 (en) * 1991-07-03 2002-08-05 電気化学工業株式会社 Allergy treatment
US5633003A (en) * 1994-03-31 1997-05-27 Cantor; Jerome O. Use of intratracheally administered hyaluronic acid to ameliorate emphysema
AU755465C (en) * 1998-06-01 2004-01-29 Fidia Farmaceutici S.P.A. Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants
JP2004513071A (en) * 2000-05-23 2004-04-30 ザ・トラスティーズ・オブ・コロンビア・ユニバーシティ・イン・ザ・シティ・オブ・ニューヨーク Method of treating respiratory disease associated with elastic fiber injury of the lung
WO2002102317A2 (en) * 2001-06-15 2002-12-27 Exhale Therapeutics, Inc. Treatment of respiratory conditions associated with bronchoconstriction with aerosolized hyaluronic acid

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101801391B (en) * 2007-07-23 2013-07-10 农业工业研究发展公司 Use of hyaluronic acid for preparing compositions particularly for improving the function of skin, eye and mucous membrane protection

Also Published As

Publication number Publication date
WO2004050187A1 (en) 2004-06-17
AU2003294100A1 (en) 2004-06-23
AU2003294100A8 (en) 2004-06-23
FR2847818A1 (en) 2004-06-04

Similar Documents

Publication Publication Date Title
NO2014021I1 (en) Bedaquiline or a pharmaceutically acceptable acid or base addition salt thereof
FR2834890B1 (en) ORODISPERSIBLE PHARMACEUTICAL COMPOSITION OF AGOMELATIN
LU91534I2 (en) "Nicotinic acid / laropiprant"
IT1313549B1 (en) HEPOTYLONE-BASED PHARMACEUTICAL FORMULATIONS 3
MA27026A1 (en) LIQUID PHARMACEUTICAL COMPOSITION
FIU20000164U0 (en) A new pharmaceutical formulation
DK1438040T3 (en) Pharmaceutical compositions containing mycophenolic acid or a mycophenolic salt
ECSP045162A (en) "PHARMACEUTICAL COMPOSITIONS BASED ON AZETIDINE DERIVATIVES"
FR2847818B1 (en) PHARMACEUTICAL COMPOSITION BASED ON HYALURONIC ACID
FR2857263B1 (en) NOVEL SOLID PHARMACEUTICAL COMPOSITION COMPRISING AMISULPRIDE
ITVA20020024A0 (en) BUILDING PRODUCTS BASED ON PURIFIED HYDROPHOBISED HYDROXYALKYLGUARUM
FR2834896B1 (en) ORODISPERSIBLE PHARMACEUTICAL COMPOSITION OF IVABRADINE
IT1283029B1 (en) PHARMACEUTICAL COMPOSITIONS BASED ON DICLOFENAC
EP1819323A4 (en) PHARMACEUTICAL COMPOSITION COMPRISING AN ANTI-NUCLEATION AGENT
ITVA20020023A0 (en) BUILDING PRODUCTS BASED ON PURIFIED HYDROXYALKYLGUARUM
FR2828804B1 (en) COSMETIC COMPLEX BASED ON MALIC ACID
FR2857593B1 (en) ORODISPERSIBLE PHARMACEUTICAL COMPOSITION OF ANTITHROMBOTIC COMPOUND
IS7581A (en) A pharmaceutical composition
FR2814368B1 (en) PHARMACEUTICAL PREPARATION BASED ON OXANS
EE200300378A (en) A pharmaceutical composition
FR2791889B1 (en) IBUPROFEN ORAL PHARMACEUTICAL SUSPENSION
FR2832313B1 (en) NEW PHARMACEUTICAL COMPOSITIONS WITH ANTI-DREPANOCYTARY FOCUS
UA5183S (en) MEDICATION VIAL "CYSTON"
UA5182S (en) MEDICINE VIAL "LIV-52"
SE0101621D0 (en) A novel pharmaceutical target

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19

PLFP Fee payment

Year of fee payment: 20